Page last updated: 2024-08-25

ferric hydroxide and Kidney Failure, Chronic

ferric hydroxide has been researched along with Kidney Failure, Chronic in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bae, SY; Baek, CH; Jang, JW; Jeon, JW; Kim, H; Kim, SB; Kim, SH; Lee, SK; Park, SK; Yang, WS	1
Münch, HG; Potthoff, SA	1
Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V	1
Danielsen, H; Madsen, S; Nyvad, O	1

Reviews

2 review(s) available for ferric hydroxide and Kidney Failure, Chronic

Article	Year
[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:24 Topics: Administration, Oral; Anaphylaxis; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Oxidative Stress; Renal Dialysis	2013
Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8 Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer	2006

Article

Year

[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].

Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:24

Topics: Administration, Oral; Anaphylaxis; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Oxidative Stress; Renal Dialysis

2013

Phosphate binders and management of hyperphosphataemia in end-stage renal disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8

Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer

2006

Trials

1 trial(s) available for ferric hydroxide and Kidney Failure, Chronic

Article	Year
Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients. Lancet (London, England), 1994, Nov-05, Volume: 344, Issue:8932 Topics: Anemia; Drug Combinations; Drug Costs; Erythropoietin; Ferric Compounds; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Renal Replacement Therapy; Solutions; Sucrose	1994

Other Studies

1 other study(ies) available for ferric hydroxide and Kidney Failure, Chronic

Article	Year
Usefulness of mid-week hemoglobin measurement for anemia management in patients undergoing hemodialysis: a retrospective cohort study. BMC nephrology, 2019, 08-02, Volume: 20, Issue:1 Topics: Anemia; Darbepoetin alfa; Female; Ferric Compounds; Hematinics; Hemoglobin A; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Sucrose; Time Factors; Weight Gain	2019